Though coverage for Wegovy (semaglutide) is generally better than for Zepbound this year, 88% of people getting Wegovy through their insurer still face hurdles, including prior authorization and required protocols in which cheaper treatments must be tried first prior to gaining access
While the medication reduces your appetite, the food choices you make still matter for your overall health and the quality of your weight loss
The relationship between GLP-1s and glaucoma implies that the risk of glaucoma is decreased in those with T2D who are using GLP-1s
Between Q4 2024 and Q1 2025, the share of Medicare patients with comorbid diabetes or obesity and MASLD who started a GLP1 rose from 13% to 19%, compared with only a modest increase from 20% to 22% among commercially insured patients
Obesity has a complex relationship with cortisol metabolism, with variable findings across studies
Seek urgent medical attention for severe vomiting, persistent abdominal pain, signs of pancreatitis, or dehydration whilst taking Wegovy